Biomarkers · Vitamins & Endocrine
Total Testosterone
Higher values go with lower risk of death. Not measured in our NHANES panel. The curve is drawn from the published study (source below).
Total Testosterone and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to the curve's reference value, drawn from the published study (source below).
Total Testosterone by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 13.7 | 25.2 | 176 | 427 | 720 | 1,673 | NHANES 2015-2016 |
| All | 40-59 | 9.91 | 17.8 | 123 | 374 | 648 | 1,700 | NHANES 2015-2016 |
| All | 60+ | 6.99 | 15.5 | 36.9 | 358 | 653 | 1,701 | NHANES 2015-2016 |
| All | all | 9.64 | 19.6 | 63.8 | 391 | 674 | 5,074 | NHANES 2015-2016 |
| Men | 20-39 | 204 | 311 | 422 | 550 | 794 | 826 | NHANES 2015-2016 |
| Men | 40-59 | 185 | 289 | 376 | 505 | 764 | 795 | NHANES 2015-2016 |
| Men | 60+ | 158 | 285 | 382 | 516 | 770 | 846 | NHANES 2015-2016 |
| Men | all | 182 | 296 | 394 | 521 | 783 | 2,467 | NHANES 2015-2016 |
| Women | 20-39 | 11.1 | 18.8 | 24.9 | 33.6 | 52.7 | 847 | NHANES 2015-2016 |
| Women | 40-59 | 8.21 | 12.9 | 17.9 | 24.2 | 43.6 | 905 | NHANES 2015-2016 |
| Women | 60+ | 5.98 | 11.0 | 16.6 | 23.9 | 44.5 | 855 | NHANES 2015-2016 |
| Women | all | 7.72 | 13.7 | 19.9 | 27.7 | 48.8 | 2,607 | NHANES 2015-2016 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in Total Testosterone, study by study
2 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| nutraceutical | Ashwagandha (Withania somnifera) root extract 300 mg twice daily for 8 weeks alongside resistance training in young men | Testosterone increase 96.2 ng/dL (95% CI 54.7-137.5) vs 18.0 ng/dL (95% CI -15.8 to 51.8) with placebo over 8 weeks (p=0.004) | RCT | Wankhede S, et al. J Int Soc Sports Nutr. 2015. Examining the effect of… |
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| diet | Three weeks of caloric restriction at 50% of energy needs in healthy non-obese men | Plasma testosterone -11% after 3 weeks of 50% caloric restriction (weight -6.0 kg) | non-randomised trial | Müller MJ, et al. The American journal of clinical nutrition. 2015. Metabolic… |
Sources
- Risk curve: Raeisi-Dehkordi H 2025 (PMID 40333346): all-cause HR 0.89 (0.83-0.97) top vs bottom tertile of total testosterone, men. Scaled to US values (NHANES).
- Raeisi-Dehkordi H, Amiri M, Beigrezaei S, Quezada-Pinedo HG, Khatami F, Alijla F, Steur M, Chatelan A, Voortman T, van der Schouw YT, Franco OH, Muka T. Endogenous Sex Steroid Hormones, Sex Hormone-Binding Globulin, and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Journal of Clinical Endocrinology & Metabolism. 2025;110(9):e3131-e3149.
Map Total Testosterone against another biomarker.
Related markers: Adiponectin · C-peptide · Dehydroepiandrosterone Sulfate (DHEA-S) · Estradiol-to-SHBG Ratio · Free Triiodothyronine (Free T3) · Insulin-like Growth Factor 1 (IGF-1) · Serum 25-Hydroxyvitamin D · Serum Cortisol